VOR BIOPHARMA
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells. Cell surface-targeted immunotherapies, such as bispecific antibodies, antibody-drug conjugates, and chimeric antigen receptor (CAR) T cells, generally target both cancer and normal cells, causing substantial toxicities and limiting their potential. The company is taking a fundamental... ly novel approach to targeting cancer selectively by developing hematopoietic stem cells (HSCs) that have been engineered to be protected from specifically targeted immunotherapies. These HSCs are designed to generate healthy, functional cells that are also protected from depletion by cancer-targeted therapies.
VOR BIOPHARMA
Industry:
Biotechnology Health Care Oncology Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vorbio.com
Total Employee:
101+
Status:
Active
Contact:
617-655-6580
Total Funding:
267.8 M USD
Technology used in webpage:
SPF Amazon IPv6 Microsoft Exchange Online Google Office 365 Mail Google Cloud Microsoft Azure DNS GoDaddy DNS Amazon Virginia Region
Similar Organizations
2seventy bio
2seventy bio is an immuno-oncology cell therapy company that discovers and develops therapies used for cancer treatment.
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Caribou Biosciences
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Cartesian Therapeutics
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
IDEAYA Biosciences
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Phio Pharmaceuticals
Phio Pharmaceuticals develops therapeutics based on ribonucleic acid interference.
Current Advisors List
Board_member
Board_member
2005-01-01
Current Employees Featured
Christopher Slapak Chief Medical Officer @ Vor Biopharma
Chief Medical Officer
2020-07-01
Robert Ang President and CEO @ Vor Biopharma
President and CEO
2019-08-01
Nathan Jorgensen Chief Financial Officer @ Vor Biopharma
Chief Financial Officer
2020-05-01
Amy Mendel Chief Legal Officer @ Vor Biopharma
Chief Legal Officer
2019-12-01
Robert Pietrusko Chief Regulatory & Quality Officer @ Vor Biopharma
Chief Regulatory & Quality Officer
2020-04-01
Tirtha Chakraborty Chief Scientific Officer @ Vor Biopharma
Chief Scientific Officer
2020-11-01
Bill Lundberg Independent Director @ Vor Biopharma
Independent Director
2019-03-01
John King Chief Commercial Officer @ Vor Biopharma
Chief Commercial Officer
2020-08-01
Siddhartha Mukherjee Founder @ Vor Biopharma
Founder
Tania Philipp Chief People Officer @ Vor Biopharma
Chief People Officer
2021-06-01
Founder
Stock Details
Investors List
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Vor Biopharma
Fidelity
Fidelity investment in Series B - Vor Biopharma
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Vor Biopharma
PureTech Health
PureTech Health investment in Series B - Vor Biopharma
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Vor Biopharma
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series B - Vor Biopharma
RA Capital Management
RA Capital Management investment in Series B - Vor Biopharma
5AM Ventures
5AM Ventures investment in Series B - Vor Biopharma
Pagliuca Family Office
Pagliuca Family Office investment in Series B - Vor Biopharma
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Vor Biopharma
Official Site Inspections
http://www.vorbio.com Semrush global rank: 1.45 M Semrush visits lastest month: 17.23 K
- Host name: 23.1.198.104.bc.googleusercontent.com
- IP address: 104.198.1.23
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Vor Biopharma"
Vor Bio | Cell & Genome Engineering Biotechnology Company
Our proprietary platform combines genome engineering, Hematopoietic Stem Cell (HSC) biology, and CAR-T cells to solve urgent unmet medical needs for patients with blood cancers. We aim …See details»
Clinical-stage Cell and Genome Engineering | Vor Bio
We are on a mission to cure blood cancers with cross-functional teams moving quickly and collaboratively on cutting-edge concepts. We are collaborators, mentors and innovators who are fueled by a shared sense of mission and a …See details»
Vision, Mission, and Values | Biotech Company | Vor Bio
Sharing ideas and exploring unexpected possibilities with an open mind are the lifeblood of what we do at Vor Bio. Our clear vision and mission give everyone an opportunity to contribute to make a real difference for cancer patients. Cure …See details»
Vor Bio - LinkedIn
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable...See details»
Vor Bio Reports Second Quarter 2024 Financial Results and …
Aug 8, 2024 · Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic …See details»
Vor Bio: Culture | LinkedIn
At Vor Bio, we are pioneering a novel, first-in-class approach that aims to transform treatment for acute myeloid leukemia (AML) and other blood cancers.See details»
Vor Bio Reports First Quarter 2022 Financial Results and Provides ...
May 12, 2022 · Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic …See details»
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han …
Sep 30, 2024 · About Vor Bio Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering …See details»
Values and Culture | Biotechnology Jobs and Careers | Vor Bio
Our values: passion, humility & fellowship drive our daily work and our aim to cure patients with AML and other blood cancers. We are pioneering a novel, first-in-class approach that shields …See details»
Working at Vor Bio - Glassdoor
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to …See details»
Vor Bio Reports Fourth Quarter and Full Year 2022 Financial …
CAMBRIDGE, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today reported financial results for the three …See details»
New Clinical Data Validates Vor Bio’s Approach of Using
Sep 5, 2024 · Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic …See details»
Vor Biopharma Appoints John King as Chief Commercial Officer
Aug 26, 2020 · Mr. King comes to Vor from Ra Pharma, recently acquired by UCB, where he was the Chief Commercial Officer. He led the organization in preparing for the global commercial …See details»
Board of Directors | Global Biotechnology Experience | Vor Bio
Vor Bio's Board of Directors offers expert global biotechnology experience and perspectives. Our Board brings an incredible track record of success to Vor Bio. Robert Ang, MBBS, MBA, is …See details»
Vor Bio Appoints Seasoned Healthcare Institutional Investor
Sep 30, 2024 · About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering …See details»
Vor to Develop Multi-Targeted CAR-Ts with Abound Bio | Vor Bio
Jun 10, 2021 · Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering an engineered hematopoietic stem cell (eHSC) therapeutic platform to …See details»
Vor Biopharma Inc. (VOR) Stock Price, Quote & News - Stock …
Nov 18, 2024 · Get a real-time Vor Biopharma Inc. (VOR) stock price quote with breaking news, financials, statistics, charts and more.See details»
The Online Reflection of Vor Bio
Aug 2, 2022 · Our Values, Vision, and Mission remain core to Vor Bio and are well understood and embraced by Voracians. What we do is completely novel, and we can do a better job of …See details»
Abortion pill access requests surge from U.S., Canadian non-profit …
23 hours ago · The Canadian non-profit organization provides online consultation and medication for women around the world seeking abortion says it has seen a fourfold increase in U.S. …See details»
Cultivating Company Culture: The Process Behind Vor Bio’s Core …
Sep 13, 2022 · Our strong company culture at Vor Bio was the primary reason we were able to navigate our way through the pandemic and keep our employees united and on track towards …See details»